Cellular Mechanisms in the Actions of Antiglaucoma Drugs

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

There are several classes of drugs currently in use for the therapeutic management of the glaucomas. Although the ocular hypotensive effects of these agents have been well characterized and described, little is known of their site of action and cellular mechanism. This review attempts to describe those cellular mechanisms that may be linked to the actions of several classes of antiglaucoma drugs. Special emphasis was placed on drug actions and 1) the adenylate cyclase system; 2) receptor-coupled phosphoinositide turnover; 3) prostaglandins and 4) ion transport processes. Models are presented depicting proposed cellular sites of the interaction of the antiglaucoma drugs with these cellular processes.

Original languageEnglish
Pages (from-to)397-422
Number of pages26
JournalJournal of Ocular Pharmacology
Volume1
Issue number4
DOIs
StatePublished - 1 Jan 1985

Fingerprint

Pharmaceutical Preparations
Ion Transport
Therapeutic Uses
Drug Interactions
Adenylyl Cyclases
Glaucoma
Prostaglandins
phosphatidylinositol receptors

Cite this

@article{0878188ede4845d3a34628652fd8368d,
title = "Cellular Mechanisms in the Actions of Antiglaucoma Drugs",
abstract = "There are several classes of drugs currently in use for the therapeutic management of the glaucomas. Although the ocular hypotensive effects of these agents have been well characterized and described, little is known of their site of action and cellular mechanism. This review attempts to describe those cellular mechanisms that may be linked to the actions of several classes of antiglaucoma drugs. Special emphasis was placed on drug actions and 1) the adenylate cyclase system; 2) receptor-coupled phosphoinositide turnover; 3) prostaglandins and 4) ion transport processes. Models are presented depicting proposed cellular sites of the interaction of the antiglaucoma drugs with these cellular processes.",
author = "Thomas Yorio",
year = "1985",
month = "1",
day = "1",
doi = "10.1089/jop.1985.1.397",
language = "English",
volume = "1",
pages = "397--422",
journal = "Journal of Ocular Pharmacology and Therapeutics",
issn = "1080-7683",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

Cellular Mechanisms in the Actions of Antiglaucoma Drugs. / Yorio, Thomas.

In: Journal of Ocular Pharmacology, Vol. 1, No. 4, 01.01.1985, p. 397-422.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cellular Mechanisms in the Actions of Antiglaucoma Drugs

AU - Yorio, Thomas

PY - 1985/1/1

Y1 - 1985/1/1

N2 - There are several classes of drugs currently in use for the therapeutic management of the glaucomas. Although the ocular hypotensive effects of these agents have been well characterized and described, little is known of their site of action and cellular mechanism. This review attempts to describe those cellular mechanisms that may be linked to the actions of several classes of antiglaucoma drugs. Special emphasis was placed on drug actions and 1) the adenylate cyclase system; 2) receptor-coupled phosphoinositide turnover; 3) prostaglandins and 4) ion transport processes. Models are presented depicting proposed cellular sites of the interaction of the antiglaucoma drugs with these cellular processes.

AB - There are several classes of drugs currently in use for the therapeutic management of the glaucomas. Although the ocular hypotensive effects of these agents have been well characterized and described, little is known of their site of action and cellular mechanism. This review attempts to describe those cellular mechanisms that may be linked to the actions of several classes of antiglaucoma drugs. Special emphasis was placed on drug actions and 1) the adenylate cyclase system; 2) receptor-coupled phosphoinositide turnover; 3) prostaglandins and 4) ion transport processes. Models are presented depicting proposed cellular sites of the interaction of the antiglaucoma drugs with these cellular processes.

UR - http://www.scopus.com/inward/record.url?scp=0022213804&partnerID=8YFLogxK

U2 - 10.1089/jop.1985.1.397

DO - 10.1089/jop.1985.1.397

M3 - Article

C2 - 2464658

AN - SCOPUS:0022213804

VL - 1

SP - 397

EP - 422

JO - Journal of Ocular Pharmacology and Therapeutics

JF - Journal of Ocular Pharmacology and Therapeutics

SN - 1080-7683

IS - 4

ER -